跳至主要内容
临床试验/NCT04687930
NCT04687930已完成4 期

Genicular Nerve Block in Juvenile Idiopathic Arthritis

Sohag University1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2020年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
104
试验地点
1
主要终点
Change in visual analogue scale over time

研究概览

简要总结

N=104 juvenile idiopathic arthritis patients diagnosed after ILAR criteria with unilateral persistent knee arthritis. They will be randomly assigned into two groups; group 1 will receive genicular nerve block, group 2 intra-articular triamcinolone. Both groups will be examined by SOLAR ultrasound scoring system, Visual analogue scale and Lysholm score at 0, 2 and 12 weeks. A semi-quantitative score will be used to assess tenderness and swelling at the same intervals.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
— 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • juvenile idiopathic arthritis with persistent knee arthritis
  • age below 16

排除标准

  • severe knee osteoarthritis
  • peripheral neuropathy,
  • psoriatic arthritis,
  • those under anticoagulant therapy, skin infection,
  • prior knee injection in the last 3 months3
  • those who have an allergy to Bupivacaine

研究组 & 干预措施

Active genicular nerve block group

Active Comparator

group 1 will receive genicular nerve block. The injection and US examination will be done by two experienced sonographers. They were blinded to clinical data. Patients will also be blinded for the injected substance. Each point will be injected with 2 ml of Lidocaine hydrochloride 2 % (Xylocaine, Astrazeneca). The injection will be done using the 3 point technique (superior medial, superior lateral, and inferior medial genicular nerves).

干预措施: genicular nerve block (Drug)

intra-articular steroid injection group

Other

while group 2 received intra-articular triamcinolone under ultrasound guidance and through injecting the supra-patellar bursa.

干预措施: intra-articular steroid injection (Drug)

结局指标

主要结局

Change in visual analogue scale over time

时间窗: Baseline, 2 weeks and 12 weeks

a graded score for pain evaluation filled by the patient graded from 0 to 10

Change in Lysholm score over time

时间窗: Baseline, 2 weeks and 12 weeks

a score to assess knee function. This questionnaire has 8 domains. A score between 95 and 100 means excellent functional performance, good 84-94, fair 65-83 and poor \<64

Change in semiquantitative score for swelling and tenderness over time

时间窗: Baseline, 2 weeks and 12 weeks

A score graded from 0 to 3; score 0 means no swelling nor tenderness and 3 means maximum swelling and tenderness

Change in SOLAR score over time

时间窗: Baseline, 2 weeks and 12 weeks

score to assess ultrasound parameters of the knee including power doppler and grey scale measures

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mahrous

Associate professor

Sohag University

研究点 (1)

Loading locations...

相似试验

已完成
3 期
Hip Denervation in Juvenile Idiopathic Arthritis With Hip ArthritisJuvenile Idiopathic ArthritisHip Arthritis
NCT04775225Sohag University120
进行中(未招募)
1 期
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial (ADJUST)juvenile-idiopathic arthritispaediatric uveitisMedDRA version: 20.0Level: LLTClassification code 10022557Term: Intermediate uveitisSystem Organ Class: 100000004853MedDRA version: 20.0Level: LLTClassification code 10033687Term: PanuveitisSystem Organ Class: 100000004853MedDRA version: 20.1Level: LLTClassification code 10036370Term: Posterior uveitisSystem Organ Class: 100000004862MedDRA version: 20.1Level: LLTClassification code 10066681Term: Acute uveitisSystem Organ Class: 100000004853MedDRA version: 20.0Level: PTClassification code 10059176Term: Juvenile idiopathic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2019-000412-29-GBF.I. Proctor Foundation, University of California San Francisco118
进行中(未招募)
1 期
Adalimumab dans l’Arthrite Juvénile Idiopathique pour le traitement de l’UVéITE (étude ADJUVITE) - ADJUVITEvéite dans l'arthrite Juvénile IdiopathiqueMedDRA version: 8.1Level: PTClassification code 10046851Term: Arthrite Idiopathique Juvénile
EUCTR2010-019441-26-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Unknown
不适用
Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or MethotrexateJuvenile Idiopathic Arthritis
NCT01399281Istituto Giannina Gaslini9,000
招募中
不适用
Clinical, Laboratory and Ultrasound Stratification of Patients With Juvenile Idiopathic ArthritisJuvenile Idiopathic Arthritis
NCT06007456IRCCS Burlo Garofolo80